Uraemic toxins and cardiovascular disease

被引：60
作者：
Vanholder, R [1 ]
Glorieux, G [1 ]
Lameire, N [1 ]
机构：
[1] Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, B-9000 Ghent, Belgium
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2003年 / 18卷 / 03期
关键词：
cardiovascular disease; uraemic toxins;
D O I：
10.1093/ndt/18.3.463
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：463 / 466
页数：4
相关论文
共 36 条
[1]   In vitro effect of advanced glycation end-products on human polymorphonuclear superoxide production [J].
Bernheim, J ;
Rashid, G ;
Gavrieli, R ;
Korzets, Z ;
Wolach, B .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (12) :1064-1069
[2]   Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management [J].
Block, GA ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1226-1237
[3]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[4]   Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Dwyer, JT ;
Heyka, RJ ;
Rocco, MV ;
Teehan, BP ;
Levey, AS .
KIDNEY INTERNATIONAL, 2000, 58 (01) :353-362
[5]  
Cozzolino M, 2001, J AM SOC NEPHROL, V12, P2511, DOI 10.1681/ASN.V12112511
[6]   Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease [J].
Drüeke, T ;
Witko-Sarsat, V ;
Massy, Z ;
Descamps-Latscha, B ;
Guerin, AP ;
Marchais, SJ ;
Gausson, V ;
London, GM .
CIRCULATION, 2002, 106 (17) :2212-2217
[7]   PARATHYROID-HORMONE AND 1,25(OH)2D3 IN CHRONIC RENAL-FAILURE [J].
FEINFELD, DA ;
SHERWOOD, LM .
KIDNEY INTERNATIONAL, 1988, 33 (06) :1049-1058
[8]  
Fleischmann EH, 2001, CLIN NEPHROL, V56, P221
[9]  
Foley RN, 1998, J AM SOC NEPHROL, V9, P267
[10]   Advanced glycation and the immune system: stimulation, inhibition or both? [J].
Glorieux, G ;
Vanholder, R ;
Lameire, N .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (12) :1015-1018
1234